Clinical Trials Browser

Phase NA × Ototoxicity × Dexamethasone × Clear all

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Phase NA Withdrawn

Ototoxicity, Neoplasms